The most recent strong inventory was Aveanna Healthcare (Avah). Stocks are doing higher, with stocks increasing 88.6% over the past month. The stock reached a new 52-week high of $7.69 in the previous session. Aveanna has earned 63.5% since the start of the year, compared to Zacks Medical Sector's -1.4% movement and Zacks Medical (9% returns in the outpatient and home healthcare industries).
The stock has an impressive record of positive revenue surprises as it has not missed revenue consensus estimates in any of the last four quarters. In its final revenue report on August 7, 2025, Aveanna reported an EPS of $0.04 on the consensus estimate, surpassing the consensus revenue estimate by 9.93%.
For the current fiscal year, Aveanna is expected to record a profit of $0.41 per share with revenue of $2.31. This represents a 600% change in EPS versus a 14.24% change in revenue. For the next fiscal year, the company is expected to earn $0.48 per share with revenue of $2.43. This represents a change of 15.48% and 5.07% from the previous year respectively.
Aveanna may be at 52 weeks' height now, but what will happen to the future of stock? An important aspect of this question is to look at metrics to determine whether the company is planning to pull back from this level.
On this side, you can see the Zacks style scores. These are because they offer investors different ways to call stocks with a comb (other than looking at the Zack Rank in Security). Individual style scores are performed from value, growth, momentum, and A to F. Investors should consider their style scores as a valuable tool that will help them select the most appropriate Zacks ranked stock based on their individual investment style.
Aveanna has a B value score. Stock growth and momentum scores are A and A, respectively.
As for its value breakdown, the stock is currently trading at an estimate of 18 times the current fiscal year EPS, which is not on par with the average 20.3 times the peer industry. On a subsequent cash flow basis, the stocks are currently trading at 45.6 times compared to the average 17.9 times for the peer group. This is not enough to put it in the top tier of all stocks that we cover from a value standpoint.
You also need to look into the Zacks rank of your inventory as it will replace any trends at the forefront of style scores. Luckily, Aveanna currently has a Zacks rank (strong purchases) thanks to an increased revenue estimate.
It is recommended to choose a Zacks rank 1 (strong buy) or 2 (purchase) and an investor carrying a style score of A or B. So it appears that Aveanna's stock has a little more room to run in the near future.
The story continues
